{"id":"W4383683701","doi":"10.58931/cibdt.2023.1s0510","title":"Targeting IL23p19 using risankizumab for the management of moderate-to-severely active Crohn's disease","year":2023,"lang":"en","type":"article","venue":"Canadian IBD Today","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Medicine; Interleukin 23; Crohn's disease; Psoriasis; Inflammatory bowel disease; Monoclonal antibody; Immunology; Ulcerative colitis; Monoclonal; Disease; Internal medicine; Interleukin 17; Antibody; Inflammation; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004642597,0.0002522072,0.0004881788,0.0009080129,0.000179432,0.0005317483,0.0002800657,0.0004610988,0.001399909],"category_scores_gemma":[0.0005856119,0.00008636316,0.0004137951,0.000448561,0.0002645557,0.0003555567,0.000227834,0.0008859087,0.0005480337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001280302,"about_ca_system_score_gemma":0.001075498,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005841857,"about_ca_topic_score_gemma":0.01764447,"domain_scores_codex":[0.9998004,0.00003811628,0.00002943949,0.00002318349,0.00008849735,0.00002030834],"domain_scores_gemma":[0.9998037,0.00006208276,0.00003712364,0.000003624684,0.00007288627,0.00002056046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003287074,0.00004642762,0.0008763867,0.00775038,0.0001643743,0.0005413301,0.00008111256,0.0003259713,0.007271726,0.00300578,0.06726404,0.9123438],"study_design_scores_gemma":[0.0001030803,0.0002341142,0.002929854,0.003389966,0.0002556636,0.002976115,0.00006338054,0.000225776,0.002091252,0.001209131,0.9865036,0.00001808676],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.0008487938,0.9939656,0.0003308403,0.00193791,0.000445002,0.00001375878,0.00002909275,0.00001762777,0.002411436],"genre_scores_gemma":[0.01059771,0.9849689,0.000581991,0.001306587,0.0008878006,0.00001284942,0.00005988009,0.000004064622,0.001580325],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005841857,"threshold_uncertainty_score":0.01161569,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02728106468797626,"score_gpt":0.2513715419572027,"score_spread":0.2240904772692264,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}